Zeng, Hao <br/><br/>
Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway.  [electronic resource] 

 -  Oncotarget  Feb 2017 
 - 10145-10160 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.14358  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Active Transport, Cell Nucleus<br/>Adaptor Proteins, Signal Transducing--genetics<br/>Angiomotins<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Bone Morphogenetic Protein 4--genetics<br/>Bone Morphogenetic Protein Receptors--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Cell Movement<br/>Cell Proliferation--drug effects<br/>Dose-Response Relationship, Drug<br/>Gene Expression Regulation, Neoplastic<br/>Hippo Signaling Pathway<br/>Humans<br/>Intercellular Signaling Peptides and Proteins--genetics<br/>Male<br/>Membrane Proteins--genetics<br/>Mice, SCID<br/>Microfilament Proteins<br/>Phosphoproteins--genetics<br/>Prostatic Neoplasms--drug therapy<br/>Protein Serine-Threonine Kinases--metabolism<br/>Pyrazoles--pharmacology<br/>Pyrimidines--pharmacology<br/>RNA Interference<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Transcription Factors<br/>Transfection<br/>YAP-Signaling Proteins